Ask questions and gain insights about this stock now with Rize AI
DHR logo

Danaher Corporation

DHR

Stock Analysis

$198.80

+0.00 (+0.00%)• Live

Danaher Corporation Analysis Dashboard - Stock Analysis and Financial Metrics

Historical Prices

for Danaher Corporation

Key Financial Metrics

for Danaher Corporation

2024 FY
P/E Ratio
38.95
Revenue Growth
-0.06%
EPS Growth
-17.24%
Market Cap
$146.51B
Dividend Yield
+0.55%
Debt/Equity
0.32
ROIC
+5.53%
FCF Yield
+3.35%
View additional metrics

Valuation

P/B Ratio2.88
EV/Sales6.76

Financial Health

Current Ratio1.43
Return on Assets+20.27%

Analyst Recommendations

for Danaher Corporation

40 analysts
Consensus: Buy

About

for Danaher Corporation

Company Details

for Danaher Corporation

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Rainer M. Blair

Employees

61,000

Market Cap

142.28B

Exchange

New York Stock Exchange

IPO Date

December 29, 1978

CIK

0000313616

ISIN

US2358511028

CUSIP

235851102

Country

US

Balance Sheet

for Danaher Corporation

Cash Flow Statement

for Danaher Corporation

Income Statement

for Danaher Corporation

Rize ist ein KI-gestütztes Investment-Research-Terminal, das eine umfassende Aktienanalyse und Einblicke über ein intuitives Dashboard bietet.

News

No news available at the moment.